<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
   <ui>ar1618</ui>
   <ji>ARJ</ji>
   <fm>
      <dochead>Poster presentation</dochead>
      <bibl>
         <title>
            <p>The cytokine memory of SmD1<sup>83-119</sup>-autoantigen-specific Th cells of systemic lupus erythematosus patients</p>
         </title>
         <aug>
            <au id="A1">
               <snm>Langer</snm>
               <fnm>S</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A2">
               <snm>Langnickel</snm>
               <fnm>D</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A3">
               <snm>Enghard</snm>
               <fnm>P</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A4">
               <snm>Burmester</snm>
               <fnm>GR</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A5">
               <snm>Hiepe</snm>
               <fnm>F</fnm>
               <insr iid="I1"/>
               <insr iid="I2"/>
            </au>
            <au id="A6">
               <snm>Riemekasten</snm>
               <fnm>G</fnm>
               <insr iid="I1"/>
            </au>
         </aug>
         <insg>
            <ins id="I1">
               <p>Department of Rheumatology and Clinical Immunology, Charit&#233; University Hospital, Humboldt University of Berlin, Germany</p>
            </ins>
            <ins id="I2">
               <p>German Rheumatism Research Center, Berlin, Germany</p>
            </ins>
         </insg>
         <source>Arthritis Research &amp; Therapy</source>
         <supplement>
            <title>
               <p>25<sup>th</sup> European Workshop for Rheumatology Research</p>
            </title>
            <sponsor>
               <note>The organizer would like to thank the following companies who have generously supported the meeting: Abbott Immunology (Main sponsor), Bristol-Myers Squibb, Schering-Plough, Wyeth, AstraZeneca, MSD, Amgen</note>
            </sponsor>
            <note>Meeting abstracts</note>
         </supplement>
         <conference>
            <title>
               <p>25<sup>th</sup> European Workshop for Rheumatology Research</p>
            </title>
            <location>Glasgow, UK</location>
            <date-range>24-27 February 2005</date-range>
         </conference>
         <issn>1478-6354</issn>
         <pubdate>2005</pubdate>
         <volume>7</volume>
         <issue>Suppl 1</issue>
         <fpage>P97</fpage>
         <xrefbib>
            <pubid idtype="doi">10.1186/ar1618</pubid>
         </xrefbib>
      </bibl>
      <history>
         <rec>
            <date>
               <day>11</day>
               <month>1</month>
               <year>2005</year>
            </date>
         </rec>
         <pub>
            <date>
               <day>17</day>
               <month>2</month>
               <year>2005</year>
            </date>
         </pub>
      </history>
      <cpyrt>
         <year>2005</year>
         <collab>BioMed Central Ltd</collab>
      </cpyrt>
   </fm>
   <bdy>
      <sec>
         <st>
            <p>Objective</p>
         </st>
         <p>The aim of the study was to analyze the cytokine memory of Th cells derived from systemic lupus erythematosus (SLE) patients and healthy donors enriched for autoantigen-specific T cells by <it>in vitro </it>stimulation with SmD1<sup>83-119</sup>, a common autoantigen in SLE.</p>
      </sec>
      <sec>
         <st>
            <p>Method</p>
         </st>
         <p>Autoreactive CD3<sup>+ </sup>T cells derived from 37 SLE patients and 14 healthy donors were enriched by repetitive <it>ex vivo </it>stimulation of peripheral blood mononuclear cells with SmD1<sup>83-119</sup>. For control, peripheral blood mononuclear cells were stimulated only with IL-2. After two rounds of antigen stimulations, cultures were stimulated with phorbol 12-myristate 13-acetate/ionomycin for intracellular cytokine staining. Frequencies of cytokine-expressing T cells were analyzed and, in SLE patients, compared with disease activities and autoantibody levels.</p>
      </sec>
      <sec>
         <st>
            <p>Results</p>
         </st>
         <p>Comparing cultures from SLE patients with those from healthy donors, SLE patients displayed higher frequencies of tumor necrosis factor alpha-positive T cells and the frequencies correlated with disease activity. SmD1<sup>83-119</sup>-induced tumor necrosis factor alpha expression correlated with serum anti-dsDNA antibody levels. The frequencies of IL-10-expressing T cells were lower in cultures from SLE patients. Cultures from patients with high frequencies of IL-10<sup>+ </sup>T cells revealed low disease activities. SmD1<sup>83-119</sup>-induced increases in IL-10-expressing T cells were associated with low anti-dsDNA and anti-SmD1<sup>83-119 </sup>antibody levels in culture supernatants.</p>
      </sec>
      <sec>
         <st>
            <p>Conclusion</p>
         </st>
         <p>The enrichment of SmD1<sup>83-119</sup>-reactive T cells by <it>in vitro </it>cultures showed that cytokine changes specifically occur in lupus patients. The results give insight into the cytokine memory of autoreactive Th cells and their role in lupus pathogenesis.</p>
      </sec>
   </bdy>
</art>
